The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.
Our team works tirelessly every day with one urgent goal in mind: Accelerating breakthroughs patients can feel in their everyday lives. We strive to make progress in the following key areas by evaluating risk, opportunities, and challenges through a patient-focused lens:
We operate with a focused sense of optimistic urgency to find a cure for Parkinson's and to ensure the development of improved therapies for people living with Parkinson's today. We won't stop until a cure is found. We're on it.
We take pride in all our accomplishments so far. But ultimately we have only one definition of success: Scientific solutions that produce tangible improvements in patients' lives.
From inception, MJFF has invested in high-risk, high-reward research targets; an approach that in 10 short years has transformed the broader approach in the PD research field.
It is accepted practice among private disease research funders that the most important decisions — how to allocate donor-raised dollars — are made by external scientific advisors and boards. We bucked this model from day one in favor of building an in-house team of formally trained PhDs and business-trained project managers.